{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:05:04Z","timestamp":1770473104647,"version":"3.49.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"4-5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[1992,1]]},"DOI":"10.3109\/10428199209051003","type":"journal-article","created":{"date-parts":[[2007,11,18]],"date-time":"2007-11-18T20:28:55Z","timestamp":1195417735000},"page":"247-252","source":"Crossref","is-referenced-by-count":3,"title":["The Present Status in All-trans Retinoic Acid (ATRA) Treatment for Acute Promyelocytic Leukemia Patients: Further Understanding and Comprehensive Strategy are Required in the Future"],"prefix":"10.1080","volume":"8","author":[{"given":"Zi-Xing","family":"Chen","sequence":"first","affiliation":[{"name":"Jiangsu Institute of Hematology, Department of Hematology, First Affiliated Hospital, Suzhou Medical College, Peoples RepublicChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei-Fang","family":"Tao","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, Department of Hematology, First Affiliated Hospital, Suzhou Medical College, Peoples RepublicChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Min","family":"Xia","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, Department of Hematology, First Affiliated Hospital, Suzhou Medical College, Peoples RepublicChina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.567.567"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.9.1704.1704"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105163242002"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.6.1413.1413"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(91)90067-4"},{"key":"e_1_2_1_7_1","volume-title":"The \u201cretinoic acid syndrome\u201d in acute promyelocytic leukemia","author":"Frankel S. R.","year":"1992","unstructured":"Frankel S. R., Eardley A., Lauwers G., Warrel R. P., Jr. The \u201cretinoic acid syndrome\u201d in acute promyelocytic leukemia. 1992, submitted)."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.2.299.299"},{"key":"e_1_2_1_9_1","first-page":"2138","article-title":"Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia","volume":"52","author":"Muindi J.","year":"1992","unstructured":"Muindi J., Frankel S. R., Huselton C., et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Research 1992; 52: 2138\u20132142","journal-title":"Cancer Research"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.112.5.965"},{"key":"e_1_2_1_11_1","first-page":"23","article-title":"Characterization of cytoplasmic retinoic acid binding protein (CRABP) during therapy of RA in promyelocytic acute leukemia","volume":"32","author":"Cornic M.","year":"1991","unstructured":"Cornic M., Delva L., Balitrand N., et al. Characterization of cytoplasmic retinoic acid binding protein (CRABP) during therapy of RA in promyelocytic acute leukemia. Proc. Am. Assoc. Cancer 1991; 32: 23","journal-title":"Proc. Am. Assoc. Cancer"},{"key":"e_1_2_1_12_1","first-page":"402","article-title":"The study on post-induction remission therapies in complete remission patients with APL induced by all-trans retinoic acid","volume":"11","author":"Sun G. L.","year":"1990","unstructured":"Sun G. L., Huang M. E., Chen S. R., et al. The study on post-induction remission therapies in complete remission patients with APL induced by all-trans retinoic acid. Chinese Journal of Hematology 1990; 11: 402","journal-title":"Chinese Journal of Hematology"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.5.1977"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90113-D"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.7.1418.1418"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V77.8.1657.1657","article-title":"Molecular evaluation of response to all-trans retinoic acid therapy in patients with acute promeylocytic leukemia","volume":"77","author":"Coco F. L.","year":"1991","unstructured":"Coco F. L., Avvisati G., Diverio D., et al. Molecular evaluation of response to all-trans retinoic acid therapy in patients with acute promeylocytic leukemia. Blood 1991; 77: 1657\u20131659","journal-title":"Blood"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.6.1571"},{"key":"e_1_2_1_18_1","first-page":"288","article-title":"The retinoic acid alpha receptor gene is frequently disrupted in its 5\u2032 part in Chinese patients with acute promyelocytic leukemia","volume":"5","author":"Chen Z.","year":"1991","unstructured":"Chen Z., Chen S. J., Tong J. H., et al. The retinoic acid alpha receptor gene is frequently disrupted in its 5\u2032 part in Chinese patients with acute promyelocytic leukemia. Leukemia 1991; 5: 288","journal-title":"Leukemia"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood.V79.3.554.554","article-title":"The t[15;17] breakpoint in acute promyelocytic leukemia cluster within two different sites of MYL gene: Targets for the detection of minimal residual disease by the polymerase chain reaction","volume":"19","author":"Chang K. S.","year":"1992","unstructured":"Chang K. S., Lu J. F., Wang G., et al. The t[15;17] breakpoint in acute promyelocytic leukemia cluster within two different sites of MYL gene: Targets for the detection of minimal residual disease by the polymerase chain reaction. Blood 1992; 19: 554\u2013558","journal-title":"Blood"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.7.2694"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.10.7.3535-3540.1990"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.5.1666"},{"key":"e_1_2_1_23_1","first-page":"6268","article-title":"Combination of retinoic acid with either sodium bytyrate, dimethyl sulfoxide or hexamethylene bisacetainide synergistically induce differentiation of the human myeloid leukemia cell line HL-60","volume":"50","author":"Breitman T. R.","year":"1990","unstructured":"Breitman T. R., He Ruyi. Combination of retinoic acid with either sodium bytyrate, dimethyl sulfoxide or hexamethylene bisacetainide synergistically induce differentiation of the human myeloid leukemia cell line HL-60. Cancer Research 1990; 50: 6268\u20136273","journal-title":"Cancer Research"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V78.1.75.75","article-title":"Development of a novel1, 25(OH)2 Vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism","volume":"78","author":"Zhou J. Y.","year":"1991","unstructured":"Zhou J. Y., Norman A. W., Akashi M., et al. Development of a novel1, 25(OH)2 Vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 1991; 78: 75\u201382","journal-title":"Blood"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1991.tb00528.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(91)90061-H"},{"key":"e_1_2_1_27_1","first-page":"646","article-title":"Terminal granulocytic maturation in acute myeloid leukemia (AML) following granulocyte colony stimulating factor (G-CSF) and retinoic acid (RA) stimulation","volume":"17","author":"Santini V.","year":"1989","unstructured":"Santini V., Delwel R., Lowenberg B. Terminal granulocytic maturation in acute myeloid leukemia (AML) following granulocyte colony stimulating factor (G-CSF) and retinoic acid (RA) stimulation. Experiental Hematology 1989; 17: 646","journal-title":"Experiental Hematology"},{"key":"e_1_2_1_28_1","first-page":"3928","article-title":"Priming of human myeloid leukemia cell line HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3\u2032,5\u2032-monophosphate-inducing agents and a T-lymphocyte derived differentiation factor","volume":"42","author":"Olsson I. L.","year":"1982","unstructured":"Olsson I. L., Breitman T. R., Gallo R. C. Priming of human myeloid leukemia cell line HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3\u2032,5\u2032-monophosphate-inducing agents and a T-lymphocyte derived differentiation factor. Cancer Research 1982; 42: 3928","journal-title":"Cancer Research"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V63.2.384.384","article-title":"Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug harringtonine","volume":"63","author":"Boyd A. W.","year":"1984","unstructured":"Boyd A. W., Sullivan J. R. Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug harringtonine. Blood 1984; 63: 384\u2013392","journal-title":"Blood"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900070606"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(90)90039-C"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428199209051003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:57:56Z","timestamp":1770404276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428199209051003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":30,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[1992,1]]}},"alternative-id":["10.3109\/10428199209051003"],"URL":"https:\/\/doi.org\/10.3109\/10428199209051003","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,1]]}}}